SPD422
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for SPD422, covering 2013-09-25 to 2016-06-08. Get the full timeline:
Most recent: Clinical Trial Update: Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia [Phase 3]